103 related articles for article (PubMed ID: 22433770)
1. Innovation and the burden of disease: retrospective observational study of new and emerging health technologies reported by the EuroScan Network from 2000 to 2009.
Martino OI; Ward DJ; Packer C; Simpson S; Stevens A
Value Health; 2012; 15(2):376-80. PubMed ID: 22433770
[TBL] [Abstract][Full Text] [Related]
2. Burden of disease, research funding and innovation in the UK: Do new health technologies reflect research inputs and need?
Ward D; Martino O; Packer C; Simpson S; Stevens A
J Health Serv Res Policy; 2013 Apr; 18(1 Suppl):7-13. PubMed ID: 27552774
[TBL] [Abstract][Full Text] [Related]
3. Early identification and assessment of new and emerging health technologies: actions, progress, and the future direction of an international collaboration--EuroScan.
Simpson S; Packer C; Carlsson P; Sanders JM; Ibarluzea IG; Fay AF; Norderhaug I
Int J Technol Assess Health Care; 2008; 24(4):518-25. PubMed ID: 18828949
[TBL] [Abstract][Full Text] [Related]
4. Use of the Internet in scanning the horizon for new and emerging health technologies: a survey of agencies involved in horizon scanning.
Douw K; Vondeling H; Eskildsen D; Simpson S
J Med Internet Res; 2003; 5(1):e6. PubMed ID: 12746211
[TBL] [Abstract][Full Text] [Related]
5. Emerging health technologies: informing and supporting health policy early.
Wild C; Langer T
Health Policy; 2008 Aug; 87(2):160-71. PubMed ID: 18295925
[TBL] [Abstract][Full Text] [Related]
6. Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries.
Barrenho E; Miraldo M; Smith PC
Health Econ; 2019 Jan; 28(1):123-143. PubMed ID: 30417950
[TBL] [Abstract][Full Text] [Related]
7. Early awareness and alert systems: an overview of EuroScan methods.
Gutierrez-Ibarluzea I; Simpson S; Benguria-Arrate G;
Int J Technol Assess Health Care; 2012 Jul; 28(3):301-7. PubMed ID: 22980708
[TBL] [Abstract][Full Text] [Related]
8. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9062):1347-52. PubMed ID: 9149696
[TBL] [Abstract][Full Text] [Related]
9. Implementing a national early awareness and alert system for new and emerging health technologies in Italy: the COTE Project.
Migliore A; Perrini MR; Jefferson T; Cerbo M
Int J Technol Assess Health Care; 2012 Jul; 28(3):321-6. PubMed ID: 22980711
[TBL] [Abstract][Full Text] [Related]
10. Global burden of disease in young people aged 10-24 years: a systematic analysis.
Gore FM; Bloem PJ; Patton GC; Ferguson J; Joseph V; Coffey C; Sawyer SM; Mathers CD
Lancet; 2011 Jun; 377(9783):2093-102. PubMed ID: 21652063
[TBL] [Abstract][Full Text] [Related]
11. EUROSCAN INTERNATIONAL NETWORK MEMBER AGENCIES: THEIR STRUCTURE, PROCESSES, AND OUTPUTS.
Packer C; Simpson S; de Almeida RT
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):78-85. PubMed ID: 26077793
[TBL] [Abstract][Full Text] [Related]
12. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
13. Scanning the horizon of obsolete technologies: possible sources for their identification.
Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Asua J; Benguria-Arrate G; Galnares-Cordero L
Int J Technol Assess Health Care; 2009 Jul; 25(3):249-54. PubMed ID: 19619342
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical innovation and the burden of disease in developing and developed countries.
Lichtenberg FR
J Med Philos; 2005 Dec; 30(6):663-90. PubMed ID: 16396790
[TBL] [Abstract][Full Text] [Related]
15. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems.
Douw K; Vondeling H
Int J Technol Assess Health Care; 2006; 22(2):177-83. PubMed ID: 16571193
[TBL] [Abstract][Full Text] [Related]
16. International diffusion of new health technologies: a ten-country analysis of six health technologies.
Packer C; Simpson S; Stevens A;
Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical portfolio management: global disease burden and corporate performance metrics.
Daems R; Maes E; Mehra M; Carroll B; Thomas A
Value Health; 2014 Sep; 17(6):732-8. PubMed ID: 25236997
[TBL] [Abstract][Full Text] [Related]
18. Part 5. Public health and air pollution in Asia (PAPA): a combined analysis of four studies of air pollution and mortality.
Wong CM; Vichit-Vadakan N; Vajanapoom N; Ostro B; Thach TQ; Chau PY; Chan EK; Chung RY; Ou CQ; Yang L; Peiris JS; Thomas GN; Lam TH; Wong TW; Hedley AJ; Kan H; Chen B; Zhao N; London SJ; Song G; Chen G; Zhang Y; Jiang L; Qian Z; He Q; Lin HM; Kong L; Zhou D; Liang S; Zhu Z; Liao D; Liu W; Bentley CM; Dan J; Wang B; Yang N; Xu S; Gong J; Wei H; Sun H; Qin Z;
Res Rep Health Eff Inst; 2010 Nov; (154):377-418. PubMed ID: 21446215
[TBL] [Abstract][Full Text] [Related]
19. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
20. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
